发明名称 |
HUMAN MONOCLONAL ANTIBODY AGAINST HEPATITIS B VIRUS SURFACE ANTIGEN (HBVSAG) |
摘要 |
Disclosed is a hybridoma cell line which produces human antibodies capable o f binding to the hepatitis B virus surface antigen (HBVsAg), as well as antibodies produced by the cell line. Also disclosed ar e various uses of said antibodies in the prevention and treatment of HBV infection. Peripheral blood lymphocytes obtained from human donors having a high titer of anti HBVsAg antibodies are activated in vitro with pokeweed mitogen and then fused with heteromyelo ma cells to generate hybridomas secreting human antibodies having a high affinity and specificity to HBVsAg.
|
申请公布号 |
CA2227548(C) |
申请公布日期 |
2004.07.20 |
申请号 |
CA19972227548 |
申请日期 |
1997.06.10 |
申请人 |
XTL BIOPHARMACEUTICALS LIMITED |
发明人 |
DAGAN, SHLOMO |
分类号 |
A61K38/00;A61P31/12;C07K16/08;(IPC1-7):C12N5/28;C07K14/02;A61K39/29;A61K39/42;G01N33/576;G01N33/577 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|